
Biocept BIOC
Quartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Biocept Kurshistorie 2011-2025 | BIOC
Kurshistorie Jährlich Biocept
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.35 | 2.8 | 5.87 | 3.1 | 19.7 | 102 | 429 | 1.28 K | 1.9 K | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.9 K | 0.35 | 416 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 19.2 | -0.49 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 21.36 | 0.47 % | $ 230 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 0.23 | -5.23 % | $ 6.75 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 39.57 | -1.3 % | $ 1.1 B | ||
|
BioNano Genomics
BNGO
|
2.79 | $ 1.52 | -0.14 % | $ 1.93 M | ||
|
DarioHealth Corp.
DRIO
|
1.53 | $ 10.02 | -0.2 % | $ 284 M | ||
|
DexCom
DXCM
|
126 | $ 67.43 | 0.01 % | $ 26 B | ||
|
Danaher Corporation
DHR
|
208 | $ 229.63 | -0.61 % | $ 168 B | ||
|
Exact Sciences Corporation
EXAS
|
50.3 | $ 101.56 | 0.01 % | $ 18.8 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 26.67 | -1.27 % | $ 806 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
9.69 | $ 19.47 | -1.32 % | $ 1.05 B | ||
|
Celcuity
CELC
|
10.1 | $ 101.84 | -0.75 % | $ 4.02 B | ||
|
Anixa Biosciences
ANIX
|
2.22 | $ 3.2 | -6.43 % | $ 102 K | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
197 | $ 226.18 | 0.11 % | $ 41 B | ||
|
Guardant Health
GH
|
47.6 | $ 103.67 | 1.26 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Illumina
ILMN
|
103 | $ 134.77 | -0.41 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
166 | $ 203.13 | -0.37 % | $ 10.4 B | ||
|
Myriad Genetics
MYGN
|
10.7 | $ 6.43 | -1.83 % | $ 583 M | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 5.0 | -1.96 % | $ 2.68 M | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 7.1 | -0.63 % | $ 1.54 B | ||
|
National Research Corporation
NRC
|
41.1 | $ 18.64 | -0.05 % | $ 457 M | ||
|
Quest Diagnostics Incorporated
DGX
|
172 | $ 175.94 | 0.03 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
0.71 | $ 6.67 | -2.2 % | $ 865 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
252 | $ 253.68 | -0.24 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 182.17 | -0.82 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
457 | $ 686.87 | -0.19 % | $ 56.6 B | ||
|
Lantheus Holdings
LNTH
|
93.4 | $ 66.5 | -0.27 % | $ 4.6 B | ||
|
Mettler-Toledo International
MTD
|
1.41 K | $ 1 414.61 | -0.25 % | $ 30 B | ||
|
Agilent Technologies
A
|
139 | $ 138.0 | -0.19 % | $ 42 B | ||
|
Pacific Biosciences of California
PACB
|
5.57 | $ 1.77 | -5.64 % | $ 449 M | ||
|
Biomerica
BMRA
|
3.13 | $ 2.7 | 2.06 % | $ 6.2 M | ||
|
Bioventus
BVS
|
5.6 | $ 7.37 | -0.14 % | $ 462 M | ||
|
NeoGenomics
NEO
|
12.1 | $ 12.24 | -0.53 % | $ 1.55 B |